triazoles has been researched along with Candidiasis in 419 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (9.55) | 18.7374 |
1990's | 45 (10.74) | 18.2507 |
2000's | 219 (52.27) | 29.6817 |
2010's | 109 (26.01) | 24.3611 |
2020's | 6 (1.43) | 2.80 |
Authors | Studies |
---|---|
Abruzzo, GK; Apgar, JM; Balkovec, JM; Dragovic, J; Fan, W; Flattery, AM; Galgoci, AM; Giacobbe, RA; Gill, CJ; Greenlee, ML; Hsu, MJ; Kahn, JN; Kirwan, R; Lee, S; Liberator, P; Liu, H; Mamai, A; Meng, D; Misura, AS; Motyl, M; Nelson, K; Parker, DL; Peel, M; Powles, M; Racine, F; Sperbeck, D; Wildonger, KJ; Wilkening, RR | 1 |
Bodai, L; Bohner, F; Gabaldón, T; Gácser, A; Kocsis, K; Nosanchuk, JD; Papp, C; Szekeres, A; Tóth, R; Vágvölgyi, C; Varga, M; Willis, JR | 1 |
Bidaud, AL; Dannaoui, E; Schwarz, P | 1 |
Abdelbary, AA; Elshafeey, AH; Moftah, NH; Mosallam, S; Ragaie, MH | 1 |
Dong, J; Kan, S; Liang, G; Liu, W; Song, N; Zhang, M; Zheng, H | 1 |
Butler-Laporte, G; Cheng, MP; Del Corpo, O; Demir, KK; Ekmekjian, T; Lee, TC; Sheppard, DC | 1 |
McCarthy, MW; Walsh, TJ | 1 |
Champleboux, M; Chauvel, M; Cornet, M; Courçon, M; d'Enfert, C; Ferri, E; Garnaud, C; Govin, J; Harbut, M; Hull, M; Kashemirov, BA; Maubon, D; McKenna, CE; Mietton, F; Petosa, C; Spittler, D; Zala, N; Zhou, Y | 1 |
Cantürk, Z; Çavuşoğlu, BK; Yurttaş, L | 1 |
Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T | 1 |
Chen, CT; Huang, MC; Huang, YJ; Lin, HC; Shen, M | 1 |
Alvarez-Moreno, C; Ariza, BE; Ceballos-Garzón, A; Cortes-Fraile, G; de la Hoz, A; Garzón, JR; Hernandez, C; Le Pape, P; Linares-Linares, MY; Morio, F; Parra-Giraldo, CM; Valderrama, SL | 1 |
Bartoszewicz, M; Król, J; Nawrot, U | 1 |
Folić, M; Janković, SM; Jović, Z; Kostić, M; Milovanović, D; Milovanović, J; Ružić Zečević, D; Stefanović, S | 1 |
Coombs, GW; Dyer, JR; Gardam, DJ; Heath, CH; Pang, S | 1 |
Barker, KS; Doorley, LA; Nishimoto, AT; Palmer, GE; Rogers, PD; Rybak, JM | 1 |
Emami, S; Ghobadi, E; Hashemi, SM; Saednia, S | 1 |
Guan, XM; Hu, YL; Li, D; Wang, LH; Weng, LX; Xu, ZH; Yang, DL; Yin, ZX; Zeng, GS; Zhang, YQ | 1 |
Abdolrasouli, A; Armstrong-James, D; Ashman, J; Chakrabarti, A; Colley, T; Dhaliwal, M; Ito, K; Kaur, H; Rapeport, G; Rudramurthy, SM; Schelenz, S; Strong, P | 1 |
Arora, R; Chaudhary, SC; Kumar, V; Sawlani, KK | 1 |
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H | 1 |
Hamada, Y; Hirayama, T; Ichibe, Y; Katori, Y; Kuroyama, M; Okuma, R; Takahashi, S | 1 |
Averette, AF; Chen, YL; Heitman, J; Lehman, VN; Perfect, JR | 1 |
Cuenca-Estrella, M; de Lucas, MP; Fusco-Almeida, AM; Lozano, E; Mendes-Giannini, MJ; Mesa-Arango, AC; Scorzoni, L; Zaragoza, O | 1 |
Barrett, DM; Gerber, JS; Larru, B | 1 |
Hatipoglu, H; Hatipoglu, N | 1 |
Coste, A; Eddouzi, J; Ischer, F; Kelly, S; Manai, M; Parker, JE; Sanglard, D; Vale-Silva, LA | 1 |
Chang, CL; Jang, HC; Jang, MJ; Kim, MN; Kim, SH; Lee, HS; Lee, K; Lee, MK; Lee, WG; Ryang, DW; Shin, JH; Shin, MG; Song, ES; Suh, SP | 1 |
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H | 1 |
Ballot, DE; Bosman, N; Cooper, PA; Nana, T; Ramdin, T | 1 |
Benjamin, DK; Ericson, J; Manzoni, P | 1 |
Andes, DR; Diekema, D; Lepak, AJ; Marchillo, K; VanHecker, J | 1 |
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
Chen, SC; Meyer, W; Middleton, PG | 1 |
Pea, F | 1 |
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
Gamaletsou, MN; Walsh, TJ | 1 |
Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó | 1 |
Forst, T; Goldenberg, R; Guthrie, R; Meininger, G; Stein, P; Vijapurkar, U; Yee, J | 1 |
Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C | 1 |
Cevallos, V; Hoover, C; Jeng, BH; Keenan, JD; Layer, N; Maxwell, AJ | 1 |
Castanheira, M; Dietrich, RR; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
Angelova, O; Auberger, J; Ditlbacher, A; Lackner, M; Lass-Flörl, C; Nachbaur, D; Orth-Höller, D | 1 |
Azie, N; Ghannoum, M; Schmitt-Hoffmann, AH; Viljoen, J | 1 |
Healy, JR; Kraft, WK; Moore, JN | 1 |
Carver, PL; Pettit, NN | 1 |
Gou, C; Li, C; Li, XZ; Li, YR; Liu, HY; Liu, JC; Piao, HR; Zhang, ML; Zheng, CJ | 1 |
Capilla, J; Fothergill, AW; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, N | 1 |
Coste, AT; Sanglard, D | 1 |
Antonelli, M; Bassetti, M; Calandra, T; Roberts, JA; Vincent, JL | 1 |
Arslan, U; Dagi, HT; Findik, D; Senkeles, C | 1 |
Angiolella, L; Castagnola, M; Iavarone, F; Leone, C; Marzano, V; Vavala, E; Vitali, A | 1 |
Mittal, A; Paliwal, S; Sharma, M; Sharma, S; Singh, A; Tilak, A; Tripathi, N | 1 |
Bergeron, MG; Boily, MJ; Boissinot, M; Boudreau, DK; Maheux, AF; Ouellette, M; Pelletier, R; Picard, FJ; Piché, Y; Roy, PH; Sellam, A; Trépanier, H | 1 |
Abid, M; Aneja, B; Azam, A; Irfan, M; Jairajpuri, MA; Kapil, C; Kavanagh, K; Maguire, R; Manzoor, N; Rizvi, MM | 1 |
Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ | 1 |
DeRemer, DL; Fisher, JF; Forseen, C; Jillella, AP; Steele, JC; Ustun, C | 1 |
Zaas, AK | 1 |
Ayala, J; Elizondo, M; González, GM | 1 |
Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S | 1 |
Bosch, M; Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A | 1 |
Hollenbach, E | 1 |
Hoppe-Tichy, T; Lichtenstern, C; Störzinger, D; Swoboda, S; Weigand, MA | 1 |
Kishel, JJ; Sivik, J | 1 |
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
Aronoff, DM; Malani, AN | 1 |
Alexander, BD; Daly, JS; Graybill, JR; Hardalo, CJ; Patino, H; Perfect, JR; Restrepo, A; Tobón, AM | 1 |
Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH | 1 |
Calandra, T; Eggimann, P; Playford, EG | 1 |
Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA | 1 |
da Silva, CF; Dalla Costa, T; de Araujo, BV; Haas, SE | 1 |
Cubillos, GF; Kett, DH | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
Almirante, B; Pemán, J | 1 |
Aher, NG; Bhat, MK; Kumar, A; Mishra, NN; Pore, VS; Sharma, A; Shukla, PK | 1 |
Nawrot, U; Nowicka, J; Wlodarczyk, K | 1 |
Auberger, J; Bellmann, R; Bellmann-Weiler, R; Joannidis, M; Lass-Flörl, C; Stein, M; Weiler, S | 1 |
Enache-Angoulvant, A; Girard, A; Hennequin, C; Poirot, JL | 1 |
Naeger-Murphy, N; Pile, JC | 1 |
Chakrabarti, A; Chatterjee, SS; Rao, KL; Shivaprakash, MR; Singh, R; Singhi, S; Varma, SC; Zameer, MM | 1 |
Marti, J | 1 |
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
Fanci, R | 1 |
Kim, SD; Lee, JJ; Lee, SJ | 1 |
Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Schmidt, S; Zhong, L | 1 |
Kida, M | 1 |
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
De Carolis, E; Fadda, G; Fiori, B; Florio, AR; La Sorda, M; Martucci, R; Posteraro, B; Sanglard, D; Sanguinetti, M | 1 |
Pérez, P; Piñar, D; Quiles, JA; Reus, S | 1 |
Denning, DW; Hope, WW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA | 1 |
Bulut, Y; Günday, E; Güven, M; Yenişehirli, G | 1 |
Iida, T; Kagoshima, Y; Kamai, Y; Konosu, T; Mori, M; Shibayama, T; Suzuki, E | 1 |
Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
Berger, N; Bonatti, H; Geltner, C; Grif, K; Lass-Flörl, C; Lechner, M; Margreiter, R; Stelzmueller, I | 1 |
Becker, J; Davison, J; Hu, W; Jiang, B; Kauffman, S; Martel, N; Martin, CE; Ocampo, P; Oh, C; Roemer, T; Sillaots, S; Trosok, S; Veillette, K; Wang, H; Xu, D; Yang, M; Zhang, L | 1 |
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
Andrade, SE; Elizondo, M; González, GM; Portillo, OJ; Robledo, M; Rodríguez, C; Uscanga, GI | 1 |
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
Fung, CP; Lee, N; Lee, SC; Lo, HJ; See, LC | 1 |
Costa, CR; de Aquino Lemos, J; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Hasimoto e Souza, LK; Jesuíno, RS; Passos, XS | 1 |
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC | 1 |
Black, TA; Chau, AS; Cornely, OA; Mann, PA; McNicholas, PM; Mendrick, C; Patel, R; Patino, H; Ullmann, AJ | 1 |
Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M | 1 |
Elizondo, M; Garza-González, E; González, GM; González, JG | 1 |
Guarro, J; Mariné, M; Pastor, FJ | 1 |
Azeredo, J; Henriques, M; Martins, M; Negri, M; Oliveira, R; Svidzinski, TI | 1 |
Al-Badriyeh, D; Davies, GE; Kong, D; Leung, L; Stewart, K | 1 |
Bertout, S; Bourgeois, N; Bousquet, PJ; Dehandschoewercker, L; Lachaud, L; Rispail, P | 1 |
Graninger, W; Kratzer, C; Lassnigg, A; Presterl, E; Tobudic, S | 1 |
Almela, M; Marco, F; Martínez, JA; Mensa, J; Ortega, M; Pitart, C; Soriano, A | 1 |
Adiri, Y; Karatela, S; Lyon, GM; Sunay, S | 1 |
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J | 1 |
Diekema, DJ; Ellis, D; Fu, W; Gibbs, DL; Ling, TA; Newell, VA; Pfaller, MA; Rodloff, A; Tullio, V | 1 |
Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F | 1 |
Barton, R; Bijie, H; Bille, J; Chang, SC; da Luz Martins, M; Diekema, DJ; Duse, A; Dzierzanowska, D; Ellis, D; Finquelievich, J; Gibbs, DL; Gould, I; Gur, D; Hoosen, A; Lee, K; Mallatova, N; Mallie, M; Newell, VA; Peng, NG; Petrikos, G; Pfaller, MA; Santiago, A; Trupl, J; VanDen Abeele, AM; Wadula, J; Zaidi, M | 1 |
López-Martínez, R | 1 |
King, AL; Massey, HD; Stolk, MJ | 1 |
Odio, CM | 1 |
Kagoshima, Y; Kamai, Y; Kobayashi, N; Konosu, T; Kubota, M; Mori, M; Shibayama, T; Suzuki, E | 1 |
Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y | 1 |
Cisneros-Lanuza, A; Díaz-Llopis, M; Duch-Samper, A; Hurtado-Sarrió, M; Peman-Garcíia, J; Vazquez-Polo, A | 1 |
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
Fujisawa, T; Kanai, K; Kawakami, K; Kuroyanagi, J; Morita, C; Sugimoto, Y; Suzuki, T; Takemura, M | 1 |
Cárdenes, D; Carrillo-Muñoz, AJ; Eraso, E; Estivill, D; Giusiano, G; Guardia, C; Hernández-Molina, JM; Marcos-Arias, C; Ortiz-Maestro, O; Quindós, G; Santos, P; Tur-Tur, C | 1 |
Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
Azevedo, AC; Bizerra, FC; Colombo, AL; da Matta, DA; de Almeida, LP; Rosas, R | 1 |
Espinosa, C; García-Vázquez, E; Gómez, J; Hernández, A; Ruiz, J | 1 |
Boyken, L; Diekema, DJ; Espinel-Ingroff, A; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Estivill, D; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C | 1 |
Bourgeois, N; Crouzet, J; Lachaud, L; Picard, E; Sotto, A | 1 |
Flynn, HW; Liggett, PE; Scartozzi, R; Tom, D | 1 |
Katragkou, A; Roilides, E | 1 |
Alexander, BD; Andes, D; Arendrup, MC; Brown, SD; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Fowler, CL; Ghannoum, MA; Johnson, EM; Knapp, CC; Motyl, MR; Ostrosky-Zeichner, L; Pfaller, MA; Walsh, TJ | 1 |
Direkze, S; Gant, V; Kibbler, C; Mansour, M; Peggs, KS; Rodriguez-Justo, M | 1 |
George, J; Reboli, AC | 1 |
Dag, I; Kiraz, N; Oz, Y | 1 |
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
da Silva, CM; de Carvalho Parahym, AM; de Oliveira, NT; Filho, GA; Leão, MP; Macario, MC; Neves, RP | 1 |
Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
Demitrovicova, A; Kisac, P; Krcmery, V | 1 |
Fortún, J | 1 |
Arancia, S; Arruda, DC; Ciociola, T; Conti, S; D'Adda, T; De Bernardis, F; Gabrielli, E; Galati, S; Magliani, W; Pericolini, E; Pertinhez, TA; Pinto, MR; Polonelli, L; Spisni, A; Travassos, LR; Vecchiarelli, A; Zanello, PP | 1 |
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
Lacroix, C; Le Pape, P; Miegeville, M; Morio, F; Pagniez, F | 1 |
Cantón, E; Martínez, JP; Pemán, J; Valentín, A | 1 |
Dag, I; Kiraz, N; Kiremitci, A; Metintas, S; Oz, Y | 1 |
Baden, LR; Boukedes, S; Camp, PC; Dietzek, A; Fuhlbrigge, AL; Goldberg, HJ; Issa, NC; Koo, S; Kubiak, DW; Marty, FM | 1 |
Maack, KH; Tarp, B | 1 |
Bader, O; Gross, U; Hull, CM; Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG; Weig, M | 1 |
Denes, E; Dupon, M; Fiorenza, F; Megherbi, M; Saint-Marcoux, F; Weinbreck, P | 1 |
Chang, YF; Lee, FL; Lee, SM; Yang, CS | 1 |
Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
Borowiec-Chłopek, Z; Czepita, D; Giedrys-Kalemba, S; Karczewicz, D; Kot, J; Lachowicz, E | 1 |
Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
Ichihara, S; Murasaki, C; Ohwada, J; Shimma, N; Umeda, I; Yamazaki, T | 1 |
Darouiche, RO; Kontoyiannis, DP; Lewis, RE; Prince, RA; Raad, II | 1 |
Danielsen, R; Einarsdóttir, HM; Gottfredsson, M | 1 |
Fukuda, H; Hayase, T; Ichihara, S; Isshiki, Y; Mizuguchi, E; Ohwada, J; Oikawa, N; Sakaitani, M; Shimma, N; Shiratori, Y; Tsukazaki, M; Umeda, I; Yamazaki, T | 1 |
Fukuoka, T; Hosokawa, T; Kamai, Y; Kubota, M; Kuwahara, S; Maeda, N; Shibayama, T; Uchida, K; Yamaguchi, H | 1 |
Andes, D; Conklin, R; Marchillo, K; Stamstad, T | 2 |
Kontoyiannis, DP; Mantadakis, E; Samonis, G | 1 |
Krawczyk, E; Luczak, M; Rokosz, A; Sulik-Tyszka, B; Swoboda-Kopec, E; Wroblewska, M | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA | 1 |
Bayer, A; Edwards, JE; Rieg, G; Spellberg, B | 1 |
Ruhnke, M | 1 |
de la Torre-Cisneros, J; DuPont, B; Espinel-Ingroff, A; Greenberg, RN; Johnson, E; Just-Nübling, G; Lutsar, I; Marr, KA; Perfect, JR; Schlamm, HT; Walsh, TJ | 1 |
Armstrong, D; Cross, EW; Perlin, DS; Safdar, A | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S | 2 |
Ullmann, AJ | 1 |
Fung, HB; Jeu, L; Lyakhovetskiy, AG; Piacenti, FJ | 1 |
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J | 1 |
Benito, R; Gil, J; Ramírez de Ocáriz, I; Rezusta, A; Rubio Calvo, MC | 1 |
MOM, AM | 1 |
BUCK, A; HEITE, HJ; LEHMANN, C | 1 |
Dromer, F; Lamer, C; Le Guillou, JL; Le Jouan, M; Martinez, V; Tod, M | 1 |
Barbour, N; Bronson, JJ; Chen, CP; Clark, J; Connolly, TP; Dali, M; Gao, Q; Golik, J; Huang, S; Hudyma, TW; Kang, SH; Knipe, J; Lamb, L; Mathew, M; Matiskella, JD; Medin, I; Mosure, K; Tejwani, R; Ueda, Y; Varia, S; Venkatesh, S; Zheng, M | 1 |
Kullberg, BJ; Ostrosky-Zeichner, L; Oude Lashof, AM; Rex, JH | 1 |
Bliss, JM; Gigliotti, F; Wellington, M | 1 |
Baron, EJ; Colombo, AL; de Bedout, C; del Palacio, A; Gibbs, DL; Girmenia, C; Hazen, KC; Sanchez-Sousa, A | 1 |
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
Andes, D; Cacciapuoti, A; Conklin, R; Ezzet, F; Krishna, G; Loebenberg, D; Marchillo, K | 1 |
Espinel-Ingroff, A; Holliday, N; Killian, SB; Knapp, CC; Messer, SA; Pfaller, M | 1 |
Casal, M; Charriel, G; Linares, MJ; Solís, F | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Dupont, B | 1 |
Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P | 1 |
Innes, JR; Moss, PJ; Thaker, HR; Varma, D; Wedgwood, K | 1 |
Rubin, ZA; Somani, J | 1 |
Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M | 1 |
Almoujahed, MO; Baran, J; Riederer, K | 1 |
Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK | 1 |
Drago, M; Morace, G; Scaltrito, MM | 1 |
Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
Bernhardt, H; Bernhardt, J; Knoke, M; Ludwig, K | 1 |
Cheng, HH; Lo, HJ; Yang, YL | 1 |
Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA | 1 |
Kleinpeter, MA | 1 |
Espinel-Ingroff, A; Jones, RN; Pfaller, MA | 1 |
Jones, AL; Pai, MP | 1 |
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
Arango, M; Correa, AL; de Bedout, C; Restrepo, A; Tobón, AM | 1 |
Carrilero, MJ; Granados, JM; Puerto, N | 1 |
Friedman, GS; Mathis, AS; Shah, NK | 1 |
Bansal, M; Fealy, S; Khazzam, M | 1 |
Perfect, JR | 3 |
Marr, K | 1 |
Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK | 1 |
Cacciapuoti, A; Gurnani, M; Halpern, J; Loebenberg, D; Norris, C; Patel, R | 1 |
Marr, KA | 1 |
Balwierz, W | 1 |
Fabry, K; Nelen, G; Verheyden, F | 1 |
Böhme, A; Haas, A; Maschmeyer, G | 1 |
Jacobs, RF; Maples, HD; Muldrew, KM; Stowe, CD | 1 |
Jang, GJ; Kim, KS; Lee, WK; Shin, WS | 1 |
Kofla, G; Ruhnke, M | 1 |
Hoshiko, S; Ohtsuka, K; Okutomi, T; Takahata, S; Uchida, K; Yamaguchi, H | 1 |
Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C | 1 |
Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
Argaud, L; Martin, O; Mohammedi, I; Piens, MA; Robert, D; Thiebaut, A | 1 |
Bennett, F; Cacciapuoti, A; Ganguly, AK; Girijavallabhan, VM; Hare, RS; Jao, E; Liu, YT; Loebenberg, D; Lovey, RG; Menzel, F; Moss, E; Nomeir, A; Patel, NM; Pike, R; Pinto, P; Saksena, AK; Wang, H | 1 |
Nagino, K; Shirasawa, H | 1 |
Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC | 1 |
Kumar, R; Naithani, R | 1 |
Marik, PE; Raman, T | 1 |
Choti, M; Magill, SS; Merz, WG; Sears, CL; Shields, C | 1 |
Barchiesi, F; Bedini, A; Borghi, V; Codeluppi, M; Esposito, R; Guaraldi, G; Mussini, C; Rumpianesi, F; Venturelli, C | 1 |
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T | 1 |
Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S | 1 |
Bal, AM | 1 |
Andes, D; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Ghannoum, MA; Johnson, EM; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG; Sheehan, DJ; Troke, P; Walsh, TJ; Warnock, DW | 1 |
Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA | 1 |
Klotz, SA | 1 |
Castro-Orjales, MJ; Collell-Llach, MD; de la Torre-Fernández, MJ; Díaz-López, MD; León, C; López-Ciudad, V; Pérez de Juan-Romero, MA; Sanz-Rodríguez, C | 1 |
Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF | 1 |
Bosch, M; Cantón, E; de Llanos, R; Jarque, I; Molina, A; Pemán, J; Salavert, M | 1 |
Alves, SH; Azevedo, AC; Boff, E; Da Matta, DA; Guarro, J; Loreto, ES; Santurio, JM | 1 |
Anstead, GM; Graybill, JR; Martinez, M | 1 |
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
Akova, M; Sahin, GO | 1 |
Aperis, G; Mylonakis, E | 1 |
Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR; Sims, CR | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Pemán, J; Zaragoza, R | 1 |
Bäsecke, J; Glass, B; Perske, C; Rüchel, R | 1 |
Kauffman, CA | 1 |
Odds, FC | 1 |
Barcs, I; Dóczi, I; Mestyán, G; Nagy, E; Nikolova, R; Puskás, E | 1 |
Groll, AH; Walsh, TJ | 1 |
Behringer, K; Cornely, OA; Krüger, K; Kurzai, O; Töx, U; Vehreschild, JJ; Wickenhauser, C | 1 |
Lill, H; Voigt, C | 1 |
Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
Manfredi, R; Sabbatani, S | 1 |
Cao, YB; Cao, YY; Gao, PH; He, QQ; Jiang, YY; Liu, CM; Liu, WX; Quan, H; Wu, QY; Zhao, JX | 1 |
Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA | 1 |
Colombo, AL; Diekema, DJ; Gibbs, DL; Kibbler, C; Newell, VA; Ng, KP; Pfaller, MA | 1 |
Bille, J; Bolay, S; Buclin, T; Calandra, T; Decosterd, LA; Majcherczyk, PA; Marchetti, O; Nieth, V; Pascual, A; Sanglard, D | 1 |
Carratalà, J; Garcia-Vidal, C | 1 |
Alcoba-Flórez, J; Arévalo, MP; Arias, A; Moragues, MD; Pontón, J; Quindós, G; Salgado-Parreño, FJ | 1 |
Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D | 1 |
Corbett, JR; McKeown, PP; Tolland, JP | 1 |
Benjamin, DK; Cotten, CM; Perfect, JR; Schell, WA; Smith, PB; Steinbach, WJ; Walsh, TJ | 1 |
Boyken, LB; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R | 1 |
Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G | 1 |
Easley, C; Kauffman, CA; Kirkpatrick, P; Malani, AN | 1 |
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S | 1 |
Falusi, E; Gergely, L; Kardos, G; Majoros, L; McNicholas, PM; Sóczó, G | 1 |
Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH | 1 |
Petrikkos, G; Skiada, A | 1 |
Arendrup, MC; Denning, DW; Diekema, DJ; Pfaller, MA; Rex, JH | 1 |
Winslow, DL | 1 |
Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J | 1 |
Lewis, RE | 1 |
Haas, A; Maschmeyer, G | 1 |
Gleissner, B; Mansmann, V; Schilling, A; Seibold, M | 1 |
Guarro, J; Pastor, FJ | 1 |
Cesur, S; Kaynak, F; Ozçelik, B; Sipahi, B; Sultan, N | 1 |
Gahn, B; Gramatzki, M; Repp, R; Schub, N | 1 |
Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
Cantón, E; Carrillo-Muñoz, A; Espinel-Ingroff, A; Martín-Mazuelos, E; Martínez, JP; Pemán, J | 1 |
Fung, HB; Schiller, DS | 1 |
Khakoo, RA; Khan, FA; Slain, D | 1 |
Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M | 1 |
Barchiesi, F; Maida, CM; Milici, ME; Scalise, G; Spreghini, E | 1 |
Mian, P; Pagani, L; Spoladore, G; Vedovelli, C | 1 |
Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A | 1 |
Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG | 1 |
Deresinski, S; Nagappan, V | 1 |
Barnes, R; Colombo, A; Diekema, DJ; Finquelievich, J; Gibbs, DL; Newell, VA; Ng, KP; Pfaller, MA; Wadula, J | 1 |
Berceanu, A; Herbrecht, R | 1 |
Imhof, A; Misselwitz, B; Schneemann, M | 1 |
Joshi, R; Kohli, V; Sachdev, P; Taneja, V | 1 |
Graybill, JR; Lewis, JS | 1 |
Barchiesi, F; Giannini, D; Maida, CM; Milici, ME; Orlando, F; Scalise, G; Spreghini, E; Tomassetti, S | 1 |
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN | 1 |
Akşit, F; Kiraz, N; Kiremitçi, A; Oz, Y | 1 |
Frampton, JE; Scott, LJ | 1 |
Plempel, M | 2 |
Janssen, PA; Van Cutsem, J; Van Gerven, F; Zaman, R | 1 |
Givner, LB; Horn, CA; Peacock, JE; Pegram, PS; Washburn, RG | 1 |
Anaissie, EJ; Uzun, O | 1 |
Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC | 1 |
Graybill, JR; Holmberg, JD; Luther, MF; Najvar, LK | 1 |
Anaissie, EJ; Dignani, MC; Karyotakis, NC | 1 |
Gearhart, MO | 1 |
Atkinson, BA; Bocanegra, R; Colombo, AL; Graybill, JR | 1 |
Gantz, NM; Hyder, SS; Manjon, JE | 1 |
Lee, JW; Walsh, TJ | 1 |
Hayashi, R; Itoh, K; Matsushita, Y; Okonogi, K; Tamura, N; Tasaka, A; Teranishi, K | 1 |
Hayashi, R; Itoh, K; Matsushita, Y; Okonogi, K; Tamura, N; Tasaka, A | 1 |
Kozuki, K; Miyauchi, H; Ohashi, N; Tanio, T | 2 |
Hata, K; Katsu, K; Kimura, J; Miki, H; Nakamura, T; Toyosawa, T | 1 |
Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T | 1 |
Correa, A; Graybill, JR; James, P; Luther, MF; Najvar, LK | 1 |
Annen, N; Araki, H; Fujimaki, K; Hayakawa, H; Hori, R; Imaizumi, H; Narita, H; Nishida, N; Shimizu, K; Watanbe, Y; Yamamoto, S; Yotsuji, A | 1 |
Cartledge, JD; Clumeck, N; De Wit, S; Denning, DW; Dupont, B; Gazzard, BG; Hawkins, DA | 1 |
Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
Cutright, JL; Fidel, PL; Sobel, JD | 1 |
Kakinuma, H; Kaku, Y; Naito, T; Tsukada, I; Tsuruoka, A; Yanagisawa, M | 1 |
Bouza, E; Muñoz, P | 1 |
Denning, DW; Law, D; Moore, CB | 1 |
Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
Kakinuma, H; Kaku, Y; Naito, T; Nara, K; Tsukada, I; Tsuruoka, A; Yanagisawa, M | 1 |
Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 2 |
Brandt, ME; Doern, GV; Hajjeh, RA; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Aoki, FH; Branchini, ML; Mikami, Y; Miyaji, M; Nishimura, K; Taguchi, H; Yamamoto, K; Yang, HC; Yazawa, K | 1 |
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
Gregory, RK; Mortimer, PS; Powles, RL; Riley, U; Smith, ML; Treleaven, JG; Wotherspoon, A | 1 |
Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H | 1 |
Hayashi, R; Hosono, H; Itoh, K; Kitazaki, T; Matsushita, Y; Okonogi, K; Tamura, N; Tasaka, A | 1 |
Coffman, S; Doern, GV; Fluit, AC; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS; Verhoef, J | 1 |
Patterson, TF | 1 |
Niki, Y | 1 |
Antonacci, B; Arnold, B; Cacciapuoti, A; Corcoran, E; Halpern, J; Hare, RS; Loebenberg, D; Mendrick, C; Menzel, F; Michalski, M; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Raynor, K; Yarosh-Tomaine, T | 1 |
Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C | 1 |
Abdel-Rahman, SM; Sabo, JA | 1 |
Bolmstrom, A; Houston, A; Jones, RN; Messer, SA; Mills, K; Pfaller, MA | 1 |
Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
Ernst, EJ; Hoffman, HL; Klepser, ME | 1 |
Krcmery, V | 1 |
Granier, F | 1 |
Müller, FM; Weig, M | 1 |
Karlsson, I; Kronvall, G | 1 |
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
Atwal, H; Daneshtalab, M; Furukawa, T; Gandhi, A; Higashitani, F; Khan, JK; Micetich, RG; Montaseri, H; Nishida, K; Poglod, M; Saito, H; Salama, SM; Simon, J; Uji, T; Unemi, N | 1 |
Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS | 1 |
Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P | 1 |
Bolmström, A; Jones, RN; Messer, SA; Mills, K; Pfaller, MA | 1 |
Odds, FC; Sanglard, D | 1 |
DE Carolis, E; Loranger, L; Marcotte, H; Pelletier, R | 1 |
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Ghannoum, MA; Kuhn, DM | 1 |
Habel, F; Hoban, D; Laverdiere, M; Restieri, C | 1 |
Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Yarosh-Tomaine, T | 2 |
Konosu, T; Oida, S; Takeda, N; Tanaka, T; Yasuda, H | 1 |
Sugar, AM | 1 |
Ackerbauer, H; Meingassner, JG; Mieth, H; Petranyi, G; Schaude, M | 1 |
Hector, RF; Yee, E | 1 |
Ryley, JF; Ryley, NG | 1 |
Bacher, J; Kelly, P; Lecciones, J; Lee, JW; Peter, J; Pizzo, PA; Thomas, V; Walsh, TJ | 1 |
Konosu, T; Oida, S; Tajima, Y; Takeda, N; Yasuda, H | 1 |
Bunin, N; Camitta, B | 1 |
Cohen, J | 1 |
Fukawa, H; Kodama, F; Maruta, A; Matsuzaki, M | 1 |
Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S | 1 |
Arai, S; Iguchi, K; Kamiya, H; Sakurai, M | 1 |
Nito, H | 1 |
Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M | 1 |
Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O | 1 |
Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K | 1 |
Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T | 1 |
Keil, TU | 1 |
Mattie, H; van Furth, R; Van t Wout, JW | 1 |
Bernard, DB; Farnham, H; Idelson, BA; Levine, J; Saunders, C; Sugar, AM | 1 |
Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D | 1 |
Ellis-Pegler, RB; Thomas, MG | 1 |
Fisher, MA; Lee, PG; Tarry, WF | 1 |
Durack, DT; Hobbs, MM; Perfect, JR; Wright, KA | 1 |
Dave, J; Hickey, MM; Wilkins, EG | 1 |
Corris, PA; Dark, JH; Freeman, R; Gould, FK; Kirk, AJ | 1 |
Hirsch, HA | 1 |
Thomason, JL | 1 |
Polak, A | 1 |
Beggs, WH; Bennett, RL; Hughes, CE; Tuna, IC | 1 |
Drouhet, E; Dupont, B | 1 |
Isalska, BJ; Stanbridge, TN | 1 |
Drew, RH; Gallis, HA; Perfect, JR | 1 |
Clayton, YM; Hay, RJ | 1 |
Hendel, L; Kieffer, M; Stenderup, A; Svejgaard, E; Walsøe, I | 1 |
Burke, J; Cope, NJ; Johnson, EM; von Fraunhofer, NA; Warnock, DW; Williams, EW | 1 |
Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
Durack, DT; Perfect, JR; Savani, DV | 1 |
Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW | 1 |
Cobo, LM; Durack, DT; Perfect, JR; Savani, DV | 1 |
Lefler, E; Stevens, DA | 1 |
73 review(s) available for triazoles and Candidiasis
Article | Year |
---|---|
Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidemia; Candidiasis; Candidiasis, Invasive; Echinocandins; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Triazoles | 2021 |
Drug development challenges and strategies to address emerging and resistant fungal pathogens.
Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Clinical Trials as Topic; Drug Design; Drug Resistance, Fungal; Echinocandins; Glycosides; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Triterpenes | 2017 |
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Triazoles; Voriconazole | 2019 |
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; Humans; Models, Molecular; Mycoses; Triazoles | 2019 |
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Infant; Japan; Male; MEDLINE; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole; Young Adult | 2013 |
Combination antifungal therapy for invasive fungal infections in children and adults.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2013 |
Background changing patterns of neonatal fungal sepsis in a developing country.
Topics: Antifungal Agents; Birth Weight; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Incidence; Infant, Newborn; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Factors; Socioeconomic Factors; South Africa; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections and treatment in cystic fibrosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole | 2013 |
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
Treatment of fungal disease in the setting of neutropenia.
Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles | 2013 |
In brief: a new formulation of posaconazole (Noxafil).
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Humans; Triazoles | 2015 |
Pharmacologic and clinical evaluation of posaconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Critical Illness; Delayed-Action Preparations; Humans; Mycoses; Triazoles | 2015 |
Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidemia; Candidiasis; Candidiasis, Invasive; Clinical Trials as Topic; Drug Resistance, Fungal; Humans; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Disease Management; Fluconazole; Humans; Intensive Care Units; Triazoles | 2016 |
Echinocandins: a wealth of choice--how clinically different are they?
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Drug Therapy, Combination; Echinocandins; Fungi; Humans; Triazoles | 2008 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Antifungals in the ICU.
Topics: Antifungal Agents; Candida; Candidiasis; Critical Illness; Echinocandins; Fluconazole; Humans; Intensive Care Units; Triazoles | 2008 |
Anidulafungin in the treatment of patients with invasive candidiasis.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
Topics: Amphotericin B; Antibodies, Fungal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Clinical Trials as Topic; DNA, Fungal; Drug Interactions; Echinocandins; Fungemia; Humans; Mycology; Mycoses; Triazoles; Yeasts | 2008 |
Clinical indications for newer antifungal agents.
Topics: Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Drug Therapy; Echinocandins; Endemic Diseases; Humans; Mycoses; Neutropenia; Triazoles; Zygomycosis | 2009 |
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Candidosis, a new challenge.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Echinocandins; Humans; Imidazoles; Naphthalenes; Nystatin; Terbinafine; Triazoles | 2010 |
[Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection].
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Candidiasis; Child; Child, Preschool; Fever; Humans; Infant; Infant, Newborn; Mycoses; Neoplasms; Neutropenia; Triazoles | 2010 |
[Nosocomial candidemia: new challenges of an emergent problem].
Topics: Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Guidelines as Topic; Humans; Prognosis; Triazoles | 2010 |
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Anidulafungin: when and how? The clinician's view.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Antifungal therapy update: new drugs and medical uses].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles | 2011 |
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles | 2003 |
[Voriconazole - applications and perspectives].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Triazoles; Voriconazole | 2002 |
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole.
Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fungi; Half-Life; Humans; Intestinal Absorption; Male; Microbial Sensitivity Tests; Pyrimidines; Randomized Controlled Trials as Topic; Scedosporium; Tissue Distribution; Triazoles; Voriconazole; Yeasts | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New antifungal agents: voriconazole and caspofungin].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature.
Topics: Aged; Antifungal Agents; Candidiasis; Catheters, Indwelling; Cefazolin; Female; Humans; Middle Aged; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2004 |
Management of invasive mycoses in hematology patients: current approaches.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Hematopoietic Stem Cell Transplantation; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides, Cyclic; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole | 2004 |
Invasive Candida infections: the changing epidemiology.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Incidence; Prevalence; Risk Factors; Triazoles; United States | 2004 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
[Voriconazole-medicalneeds, evidence, potential for the future].
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Candida; Candidiasis; Guinea Pigs; Humans; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2005 |
Fungal infections in bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Clinical efficacy of new antifungal agents.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Diarrhea; Exanthema; Humans; Mycoses; Nausea; Peptides, Cyclic; Triazoles; Vomiting; Zygomycosis | 2006 |
Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Humans; Nitriles; Pyridines; Triazoles | 2006 |
Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Rabbits; Rats; Treatment Outcome; Triazoles | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Recent advances in antifungal chemotherapy.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Double-Blind Method; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Mycoses; Peptides, Cyclic; Randomized Controlled Trials as Topic; Triazoles | 2007 |
Pharmacodynamic implications for use of antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Microbial Sensitivity Tests; Polyenes; Triazoles | 2007 |
[The role of voriconazole in the treatment of emerging mycoses].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
Posaconazole: an extended-spectrum triazole antifungal agent.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis; Controlled Clinical Trials as Topic; Disease Models, Animal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2007 |
Fungicidal versus Fungistatic: what's in a word?
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials as Topic; Cryptococcosis; Cryptococcus; Echinocandins; Humans; Meningitis, Cryptococcal; Microbiological Techniques; Polyenes; Triazoles | 2008 |
Posaconazole : a review of its use in the prophylaxis of invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Cost-Benefit Analysis; Drug Interactions; Drug Resistance, Fungal; Humans; In Vitro Techniques; Triazoles | 2008 |
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Drug Administration Routes; Hematopoietic Cell Growth Factors; Humans; Immunocompromised Host; Leukocyte Transfusion; Mycoses; Neoplasms; Neutropenia; Triazoles | 1995 |
Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity.
Topics: Administration, Oral; Alanine Transaminase; Aspartate Aminotransferases; Candidiasis; Chemical and Drug Induced Liver Injury; Female; Fluconazole; Hospitals, Teaching; Humans; Liver Diseases; Liver Function Tests; Middle Aged; Triazoles; Urinary Tract Infections | 1994 |
Prevention of invasive fungal infections in patients with neoplastic disease.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cytokines; Drug Administration Routes; Humans; Imidazoles; Neoplasms; Opportunistic Infections; Polyenes; Triazoles | 1993 |
[Fungal infections in patients undergoing solid organ transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Celiac Artery; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Mucormycosis; Mycoses; Postoperative Complications; Risk Factors; Thrombosis; Time Factors; Transplantation; Triazoles | 1997 |
Role of newer azoles in surgical patients.
Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Humans; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 1999 |
Novel triazole antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles | 2000 |
[Invasive fungal infections. Epidemiology and new therapies].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Microbial; Humans; Immunocompromised Host; Incidence; Nystatin; Risk Factors; Triazoles | 2000 |
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Oxidoreductases; Sterol 14-Demethylase; Triazoles | 2002 |
Voriconazole -- better chances for patients with invasive mycoses.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole | 2002 |
15 trial(s) available for triazoles and Candidiasis
Article | Year |
---|---|
Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.
Topics: Administration, Topical; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Carriers; Drug Delivery Systems; Factor Analysis, Statistical; Humans; Infant; Liposomes; Male; Microbial Sensitivity Tests; Particle Size; Rats; Rats, Wistar; Skin; Skin Absorption; Static Electricity; Suspensions; Triazoles | 2021 |
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.
Topics: Blood Glucose; Blood Pressure; Canagliflozin; Candidiasis; Diabetes Mellitus, Type 2; Diuretics, Osmotic; Double-Blind Method; Drug Therapy, Combination; Female; Genital Diseases, Female; Genital Diseases, Male; Glucosides; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Thiophenes; Treatment Outcome; Triazoles; Weight Loss | 2014 |
A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Male; Nitriles; Pyridines; Triazoles | 2015 |
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Triazoles; Young Adult | 2009 |
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Topics: Antifungal Agents; Candida; Candidiasis; Data Interpretation, Statistical; Drug Resistance, Fungal; Endpoint Determination; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2006 |
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Candidiasis, Oral; Double-Blind Method; Ethnicity; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pharyngeal Diseases; Probability; Treatment Outcome; Triazoles | 2006 |
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
Topics: Adult; Antifungal Agents; Area Under Curve; Biological Assay; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Reproducibility of Results; Spectrophotometry, Ultraviolet; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles | 2007 |
A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Recurrence; Treatment Outcome; Triazoles | 1997 |
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Consumer Product Safety; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2001 |
[Clinical study of fluconazole on deep-seated fungal infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Cryptococcosis; Drug Tolerance; Female; Fluconazole; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Triazoles | 1989 |
Clinical evaluation of terconazole. European experience.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Clotrimazole; Europe; Female; Formularies as Topic; Humans; Miconazole; Multicenter Studies as Topic; Suppositories; Triazoles; Vaginal Creams, Foams, and Jellies; Vulvovaginitis | 1989 |
Clinical evaluation of terconazole. United states experience.
Topics: Antifungal Agents; Candidiasis; Consumer Product Safety; Female; Humans; Multicenter Studies as Topic; Random Allocation; Suppositories; Triazoles; United States; Vulvovaginitis | 1989 |
Fluconazole in the management of patients with chronic mucocutaneous candidosis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Fluconazole; Humans; Triazoles | 1988 |
331 other study(ies) available for triazoles and Candidiasis
Article | Year |
---|---|
MK-5204: An orally active β-1,3-glucan synthesis inhibitor.
Topics: Administration, Oral; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Glucosyltransferases; Glycosides; Half-Life; Mice; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Triazoles; Triterpenes | 2020 |
Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
Topics: Animals; Antifungal Agents; Candida parapsilosis; Candidiasis; Drug Resistance, Fungal; Evolution, Molecular; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Stress, Physiological; Triazoles | 2020 |
In vitro synergy of isavuconazole in combination with colistin against Candida auris.
Topics: Agar; Antifungal Agents; Candida; Candidiasis; Colistin; Colony Count, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2020 |
In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Thiazoles; Triazoles; Vagina | 2021 |
Selective BET bromodomain inhibition as an antifungal therapeutic strategy.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Azabicyclo Compounds; Azepines; Benzodiazepines; Binding Sites; Candida albicans; Candidiasis; Crystallography, X-Ray; Fungal Proteins; Gene Expression; Humans; Mice; Models, Molecular; Molecular Targeted Therapy; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Pyridines; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Transcription Factors; Triazoles | 2017 |
The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Triazoles | 2018 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2018 |
Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Humans; Light; Microbial Sensitivity Tests; Photochemotherapy; Plankton; Tolonium Chloride; Triazoles | 2018 |
First report of sporadic cases of Candida auris in Colombia.
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colombia; Disease Outbreaks; Drug Resistance, Multiple, Fungal; Female; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Sequence Analysis, DNA; Triazoles | 2018 |
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Candida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015.
Topics: Aged; Antifungal Agents; Australia; Bone and Bones; Candida; Candidiasis; Chronic Disease; Fatal Outcome; Humans; Kenya; Male; Osteomyelitis; Tomography, X-Ray Computed; Travel; Triazoles; Whole Genome Sequencing | 2019 |
Abrogation of Triazole Resistance upon Deletion of
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida; Candidiasis; CRISPR-Associated Protein 9; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Microorganisms, Genetically-Modified; Triazoles | 2019 |
Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Burkholderia cenocepacia; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatty Acids, Monounsaturated; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles | 2019 |
In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
Topics: Antifungal Agents; Asia; Benzamides; Candida; Candida parapsilosis; Candidiasis; Humans; Microbial Sensitivity Tests; Tertiary Care Centers; Triazoles; United Kingdom; United States | 2019 |
Native aortic valve fungal endocarditis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aortic Valve; Candida albicans; Candidiasis; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis; Follow-Up Studies; Heart Valve Diseases; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Ergosterol; Lipopeptides; Male; Mice; Molecular Sequence Data; Mutation; Sequence Homology, Nucleic Acid; Tacrolimus; Triazoles | 2013 |
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazole; Lepidoptera; Pyrimidines; Triazoles; Voriconazole | 2013 |
Candida krusei arthritis in an adolescent with acute myelogenous leukemia.
Topics: Adolescent; Antifungal Agents; Arthritis, Infectious; Candida; Candidiasis; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2013 |
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Base Sequence; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyenes; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Triazoles; Tunisia; Voriconazole | 2013 |
In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2013 |
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Nitriles; Opportunistic Infections; Pyridines; Triazoles | 2013 |
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole | 2013 |
Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Pyridines; Species Specificity; Triazoles | 2013 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2014 |
Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cell Count; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Drug Contamination; Endothelium, Corneal; Gentamicins; Humans; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.
Topics: Antifungal Agents; Candida; Candidiasis; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Global Health; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; RNA, Ribosomal, 28S; Sequence Analysis, DNA; Triazoles | 2014 |
Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Administration Schedule; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Triazoles; Trichosporon; Trichosporonosis | 2015 |
Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety.
Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Escherichia coli; Escherichia coli Infections; Humans; Rhodanine; Staphylococcal Infections; Staphylococcus aureus; Thiones; Triazoles | 2015 |
Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection.
Topics: Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Kidney; Male; Mice; Proteoglycans; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2016 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole | 2016 |
Cell wall composition and biofilm formation of azoles-susceptible and -resistant Candida glabrata strains.
Topics: Adhesiveness; Antifungal Agents; Azoles; Biofilms; Candida glabrata; Candidiasis; Carbohydrate Metabolism; Cell Wall; Drug Resistance, Multiple, Fungal; Fungal Polysaccharides; Fungal Proteins; Gene Expression Regulation, Fungal; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mutation; Proteomics; Species Specificity; Surface Properties; Triazoles; Two-Dimensional Difference Gel Electrophoresis | 2017 |
Identification of novel antifungal lead compounds through pharmacophore modeling, virtual screening, molecular docking, antimicrobial evaluation, and gastrointestinal permeation studies.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Aspergillosis; Aspergillus niger; Candida; Candidiasis; Gastrointestinal Tract; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Permeability; Triazoles | 2017 |
Use of phylogenetical analysis to predict susceptibility of pathogenic Candida spp. to antifungal drugs.
Topics: Antifungal Agents; Base Sequence; Biological Evolution; Candida; Candidiasis; Databases, Nucleic Acid; DNA, Fungal; Echinocandins; Genes, Essential; Genes, Fungal; Microbial Sensitivity Tests; Multigene Family; Phylogeny; Polyenes; Triazoles | 2016 |
Effect of novel triazole-amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies.
Topics: Amino Acids; Antifungal Agents; Candida; Candidiasis; Fluconazole; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Sterol 14-Demethylase; Triazoles; Virulence | 2016 |
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem cell transplantation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida glabrata; Candidiasis; Chemoprevention; Fatal Outcome; Humans; Male; Middle Aged; Stem Cell Transplantation; Triazoles | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult | 2009 |
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation.
Topics: Aged; Antifungal Agents; Aspergillosis; Candidiasis; Critical Care; Cross Infection; Humans; Middle Aged; Mycoses; Postoperative Complications; Triazoles | 2008 |
Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Patient Compliance; Patient Education as Topic; Triazoles | 2008 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Voriconazole-induced photosensitivity.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Humans; Male; Middle Aged; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2008 |
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycoses; Organ Transplantation; Postoperative Complications; Retrospective Studies; Safety; Treatment Outcome; Triazoles | 2008 |
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2009 |
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Kidney; Male; Mice; Neutropenia; Nitriles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats.
Topics: Animals; Antifungal Agents; Area Under Curve; Candidiasis; Kidney; Male; Microdialysis; Models, Animal; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Serum; Triazoles; Voriconazole | 2009 |
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Global Health; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2009 |
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Triazoles | 2009 |
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Triazole-resistant candidaemia following posaconazole exposure.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fungemia; Humans; Male; Microbial Sensitivity Tests; Triazoles; Young Adult | 2009 |
In vitro activity of caspofungin and voriconazole against uncommon Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Recent experience with fungaemia: change in species distribution and azole resistance.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Child; Drug Resistance, Fungal; Fungemia; Humans; India; Risk Factors; Treatment Outcome; Triazoles | 2009 |
Candida parapsilosis endocarditis in aged patient.
Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Topical and oral voriconazole in the treatment of fungal keratitis.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Cornea; Diagnosis, Differential; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole | 2009 |
Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions.
Topics: Administration, Oral; Algorithms; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Theoretical; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2009 |
[Two cases of mycoses associated with hematologic disease].
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2009 |
[Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Bioprosthesis; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Heart Valve Prosthesis; Humans; Lipopeptides; Liposomes; Male; Middle Aged; Photosensitivity Disorders; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2010 |
Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect.
Topics: Animals; Antifungal Agents; Candidiasis; Kidney; Male; Mice; Models, Theoretical; Nitriles; Proportional Hazards Models; Pyridines; Triazoles | 2009 |
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Synthesis, cleavage, and antifungal activity of a number of novel, water-soluble ester prodrugs of antifungal triazole CS-758.
Topics: Animals; Antifungal Agents; Candidiasis; Humans; Mice; Microsomes, Liver; Prodrugs; Rats; Triazoles; Water | 2009 |
Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Kidney; Male; Mice; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 2009 |
Infections caused by Candida krusei in five transplant and two surgical patients.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Echinocandins; Female; Genotype; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycological Typing Techniques; Organ Transplantation; Postoperative Complications; Pyrimidines; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Chemical genetic profiling and characterization of small-molecule compounds that affect the biosynthesis of unsaturated fatty acids in Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cerulenin; Cluster Analysis; Fatty Acid Desaturases; Fatty Acids, Unsaturated; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Hyphae; Male; Mice; Mice, Inbred ICR; Molecular Structure; Mutation; Stearoyl-CoA Desaturase; Survival Rate; Thiazoles; Time Factors; Triazoles; Virulence | 2009 |
Anidulafungin treatment of candidal central nervous system infection in a murine model.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole | 2009 |
Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
Topics: Administration, Intravaginal; Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Mice; Mice, Inbred BALB C; Pyrimidines; Treatment Outcome; Triazoles; Vagina; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2009 |
Effects of antifungal agents in sap activity of Candida albicans isolates.
Topics: Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2010 |
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles | 2010 |
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Random Allocation; Triazoles; Vaginitis | 2011 |
Efficacy of posaconazole in a murine disseminated infection by Candida tropicalis.
Topics: Animals; Antifungal Agents; Body Burden; Candida tropicalis; Candidiasis; Dose-Response Relationship, Drug; Immunosuppression Therapy; Kaplan-Meier Estimate; Male; Mice; Microbial Sensitivity Tests; Survival; Triazoles | 2010 |
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization; Cell Adhesion; Cells, Cultured; Enzymes; Epithelial Cells; Equipment and Supplies; Fluconazole; Fungal Proteins; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Urine; Virulence Factors; Voriconazole | 2010 |
Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Statistics as Topic; Triazoles; Voriconazole | 2010 |
In vitro activity of antifungal combinations against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Austria; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fungemia; Humans; Intensive Care Units; Lipopeptides; Microbial Sensitivity Tests; Triazoles | 2010 |
Candida spp. bloodstream infection: influence of antifungal treatment on outcome.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome; Triazoles | 2010 |
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Topics: Africa; Americas; Antifungal Agents; Asia; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Europe; Fluconazole; Geography; Humans; Microbial Sensitivity Tests; Middle East; Pyrimidines; Triazoles; Voriconazole | 2010 |
Renal allograft loss due to overwhelming invasive Candida infection.
Topics: Adult; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Design, synthesis and antifungal activity of the novel water-soluble prodrug of antifungal triazole CS-758.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Humans; Mice; Microsomes, Liver; Mycoses; Prodrugs; Rats; Solubility; Triazoles | 2010 |
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Caspofungin; Corneal Ulcer; Drug Resistance, Fungal; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Novel antifungal agents: triazolopyridines as inhibitors of beta-1,6-glucan synthesis.
Topics: Antifungal Agents; beta-Glucans; Candida; Candidiasis; Drug Stability; Humans; Imidazoles; Microsomes, Liver; Pyrazoles; Pyridines; Saccharomyces cerevisiae; Triazoles | 2010 |
Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles; Yeasts | 2010 |
Clinical features and outcomes of four patients with invasive fungal sinusitis.
Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2011 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of ep
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles | 2011 |
A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Histocytochemistry; Humans; Male; Microbial Sensitivity Tests; Microscopy; Osteitis; Pyrimidines; Triazoles; United States; Vascular Surgical Procedures; Voriconazole | 2011 |
Postoperative endophthalmitis caused by Candida parapsilosis: clinical features and treatment outcomes.
Topics: Aged; Antifungal Agents; Candidiasis; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Pseudophakia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2011 |
Candida kefyr fungal enteritis following autologous BMT.
Topics: Bone Marrow Transplantation; Candida; Candidiasis; Endoscopy; Enteritis; Hematologic Neoplasms; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Triazoles; Waldenstrom Macroglobulinemia | 2012 |
Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles | 2011 |
Invasive infection in an acute myeloblastic leukemia patient due to triazole-resistant Candida tropicalis.
Topics: Aged; Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Shock, Septic; Triazoles | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.
Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Slovakia; Treatment Outcome; Triazoles | 2011 |
Peptides of the constant region of antibodies display fungicidal activity.
Topics: Animals; Antibodies; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Erythrocytes; Female; Hemolysis; Humans; Immunoglobulin A; Immunoglobulin Constant Regions; Immunoglobulin G; Immunoglobulin M; Lipopeptides; Malassezia; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Triazoles | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
Topics: Adult; Amino Acid Substitution; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Membrane; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Gene Expression Profiling; Humans; Mice; Microbial Sensitivity Tests; Middle Aged; Mutant Proteins; Oxidoreductases; Pyrimidines; Sterols; Triazoles; Virulence; Voriconazole | 2012 |
Voriconazole inhibits biofilm formation in different species of the genus Candida.
Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Humans; Pyrimidines; Staining and Labeling; Tetrazolium Salts; Triazoles; Voriconazole | 2012 |
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2013 |
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Echinocandins; Female; Humans; Lipopeptides; Lung Transplantation; Male; Micafungin; Middle Aged; Mycoses; Risk; Time Factors; Triazoles | 2012 |
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pyrimidines; Saccharomyces cerevisiae; Steroid Isomerases; Sterols; Triazoles; Voriconazole | 2012 |
Voriconazole stability in cement spacers.
Topics: Antifungal Agents; Arthroplasty, Replacement, Hip; Biofilms; Bone Cements; Candida glabrata; Candidiasis; Caspofungin; Device Removal; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Therapy, Combination; Echinocandins; Hip Prosthesis; Humans; Infusions, Intravenous; Lipopeptides; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole for Candida endophthalmitis.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Pyrimidines; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Urine; Voriconazole | 2012 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
[Endophthalmitis in course of candidosis--a case report].
Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Azoles; Candida albicans; Candidiasis; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prodrugs; Rats; Solubility; Thiazoles; Triazoles | 2002 |
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half-Life; Microbial Sensitivity Tests; Microscopy, Electron; Pyrimidines; Triazoles; Voriconazole | 2002 |
Successful treatment of Candida glabrata myocarditis with voriconazole.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Follow-Up Studies; Fungemia; Humans; Male; Myocarditis; Pyrimidines; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Biotransformation; Candidiasis; Chemical Phenomena; Chemistry, Physical; Drug Design; Half-Life; Haplorhini; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Models, Molecular; Molecular Conformation; Prodrugs; Rats; Solubility; Solvents; Triazoles; Water | 2003 |
Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Male; Mice; Microbial Sensitivity Tests; Oropharynx; Tongue; Triazoles | 2003 |
In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.
Topics: Animals; Antifungal Agents; Area Under Curve; Candidiasis; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2003 |
Susceptibility of clinical isolates of Candida glabrata to new triazoles.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles | 2003 |
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2003 |
Lack of cross-hepatotoxicity between fluconazole and voriconazole.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Liver; Liver Function Tests; Male; Pyrimidines; Transaminases; Triazoles; Voriconazole | 2003 |
Prospective epidemiologic analysis of triazole-resistant nosocomial Candida glabrata isolated from patients at a comprehensive cancer center.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Cross Infection; Drug Resistance, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Prospective Studies; Random Amplified Polymorphic DNA Technique; Triazoles | 2002 |
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2003 |
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole | 2003 |
[Update on voriconazole].
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2003 |
[Mycostatin: a new fungistatic antibiotic for the treatment of moniliasis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Candidiasis; Dermatologic Agents; Nystatin; Triazoles | 1955 |
[QUANTITATIVE STUDIES ON THE FUNGISTATIC ACTIVITY OF HUMAN SERUM TOWARDS CANDIDA ALBICANS].
Topics: Blood; Candida; Candida albicans; Candidiasis; Culture Media; Humans; Phenols; Research; Triazoles | 1964 |
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Kidney; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2003 |
Serum voriconazole levels following administration via percutaneous jejunostomy tube.
Topics: Aged; Candida glabrata; Candidiasis; Drug Administration Routes; Humans; Jejunostomy; Male; Pyrimidines; Triazoles; Voriconazole | 2003 |
Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Stability; Female; Humans; Indicators and Reagents; Infusions, Intravenous; Mice; Mice, Inbred ICR; Prodrugs; Rats; Solubility; Structure-Activity Relationship; Survival; Thiazoles; Triazoles | 2003 |
Voriconazole--superior in antimycotic treatment.
Topics: Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Female; Humans; Male; Pyrimidines; Sensitivity and Specificity; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole salvage treatment of invasive candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Assessment; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Diffusion; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Triazoles | 2004 |
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Colorimetry; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Reproducibility of Results; Sensitivity and Specificity; Triazoles | 2004 |
Comparison of two microdilution methods for testing susceptibility of Candida spp. to voriconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Microbial Sensitivity Tests; Mycology; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Fusarium; Humans; Immunocompromised Host; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles | 2004 |
Use of voriconazole in candida retinitis.
Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fatal Outcome; Female; Humans; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
Caspofungin: new indication. No progress in invasive candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; France; Humans; Peptides; Pyrimidines; Triazoles | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2004 |
Fungal peritonitis at a tertiary care community teaching hospital: epidemiology, treatments, and outcome over a 3 year timespan.
Topics: Antifungal Agents; Candidiasis; Hospitals, Teaching; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prognosis; Treatment Outcome; Triazoles | 2004 |
Alternatives to amphotericin B for Candida rugosa infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2004 |
Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2004 |
In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
Topics: Antifungal Agents; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Humans; In Vitro Techniques; Italy; Microbial Sensitivity Tests; Pyrimidines; Sampling Studies; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles; Yeasts | 2004 |
Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Epithelial Cells; Esophagitis; Esophagus; Fluconazole; Humans; Microbial Sensitivity Tests; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro activity of voriconazole against Candida species isolated in Taiwan.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2004 |
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2004 |
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Thiazoles; Triazoles; Voriconazole | 2004 |
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Posaconazole therapy for severe abdominal candidiasis: a case report.
Topics: Abdomen; Aged; Antifungal Agents; Candidiasis; Cysts; Female; Humans; Liver Diseases; Postoperative Complications; Severity of Illness Index; Triazoles | 2004 |
[Efficiency of voriconazole in fungal keratitis caused by candida albicans].
Topics: Aged; Antifungal Agents; Candidiasis; Female; Humans; Keratitis; Pyrimidines; Triazoles; Voriconazole | 2004 |
Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2004 |
Candida infection of the subacromial bursa. A case report.
Topics: Acromion; Aged; Anti-Inflammatory Agents; Antifungal Agents; Bupivacaine; Bursa, Synovial; Bursitis; Candidiasis; Decompression, Surgical; Humans; Injections, Intra-Articular; Lidocaine; Male; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Shoulder Impingement Syndrome; Triazoles; Voriconazole | 2005 |
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole | 2005 |
Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Male; Mice; Survival Analysis; Triazoles | 2005 |
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2004 |
Infection of a total knee prosthesis by Candida glabrata: a case report.
Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Knee; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Intravenous voriconazole therapy in a preterm infant.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Pyrimidines; Triazoles; Voriconazole | 2005 |
Treatment of candida chorioretinitis with voriconazole.
Topics: Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fungemia; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Fluconazole; Injections, Intravenous; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Microbial Sensitivity Tests; Species Specificity; Triazoles | 2005 |
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Emergence of Candida albicans fungemia during voriconazole therapy.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5].
Topics: Alcohols; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Haplorhini; Humans; Immunosuppressive Agents; Mice; Models, Chemical; Time Factors; Triazoles | 2006 |
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole | 2005 |
Voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole | 2005 |
Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
Topics: Antifungal Agents; Blood; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Middle Aged; Triazoles | 2006 |
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cross Infection; Drug Resistance, Fungal; Female; Fungemia; Hospitals, University; Humans; Infant; Infant, Newborn; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Triazoles | 2006 |
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Candidaemia secondary to intravascular catheter colonisation?
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Equipment Contamination; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Oropharyngeal candidiasis: a new treatment option.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Clinical Trials as Topic; Humans; Pharyngeal Diseases; Triazoles | 2006 |
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Quinazolines; Thiazoles; Triazoles | 2006 |
Control of a Candida glabrata prosthetic endovascular infection with posaconazole.
Topics: Candida glabrata; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Triazoles | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Triazoles | 2006 |
Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Macrophages; Pyrimidines; Triazoles; Voriconazole | 2006 |
A case of pulmonary aspergillosis with lack of response to caspofungin.
Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2006 |
Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method.
Topics: Candida; Candidiasis; Fluconazole; Humans; Image Processing, Computer-Assisted; Microbial Sensitivity Tests; Microscopy, Video; Pyrimidines; Triazoles; Voriconazole | 2006 |
Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.
Topics: Adult; Antifungal Agents; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Esophagitis; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous; Triazoles | 2006 |
[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].
Topics: Adult; Antifungal Agents; Candidiasis; Cervical Vertebrae; Combined Modality Therapy; Discitis; Epidural Abscess; Fluconazole; Follow-Up Studies; Head Movements; Humans; Lung Diseases, Fungal; Male; Multiple Trauma; Pyrimidines; Radiography; Triazoles; Voriconazole | 2006 |
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro and in vivo activities of HQQ-3, a new triazole antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis; Mice; Microbial Sensitivity Tests; Triazoles | 2006 |
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Health; Humans; Lipopeptides; Peptides, Cyclic; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2006 |
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2006 |
Echinocandins for candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods.
Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Indicator Dilution Techniques; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Reference Standards; Triazoles; Voriconazole; Yeasts | 2006 |
Voriconazole-induced pseudoporphyria.
Topics: Antifungal Agents; Candidiasis; Drug Eruptions; Female; Humans; Middle Aged; Porphyria, Acute Intermittent; Pyrimidines; Triazoles; Voriconazole | 2007 |
Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Hypercalcemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.
Topics: Agar; Antifungal Agents; Candida; Candidiasis; Culture Media; Disk Diffusion Antimicrobial Tests; Humans; Microbial Sensitivity Tests; Triazoles | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2007 |
Posaconazole.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Capsules; Drug Approval; Drug Design; Economics, Pharmaceutical; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Molecular Structure; Randomized Controlled Trials as Topic; Suspensions; Technology, Pharmaceutical; Treatment Failure; Triazoles; United States | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2007 |
Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Dimethyl Sulfoxide; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Polyethylene Glycols; Solvents; Triazoles | 2007 |
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromatography, High Pressure Liquid; Culture Media; Dose-Response Relationship, Drug; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2007 |
Does one voriconazole breakpoint suit all Candida species?
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2007 |
Posaconazole for azole-refractory candidiasis in patients with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Administration Schedule; Esophageal Diseases; Humans; Mouth Diseases; Pharyngeal Diseases; Triazoles | 2007 |
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2007 |
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistance, Fungal; Fluconazole; Humans; Injections, Intravenous; Molecular Structure; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Triazoles | 2008 |
In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Sputum; Triazoles; Voriconazole | 2007 |
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2007 |
Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Reference Standards; Reproducibility of Results; Triazoles | 2008 |
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2008 |
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Administration Schedule; Echinocandins; Humans; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Managing Candida endophthalmitis (Recurrent Candida albicans endophthalmitis in an immunocompromised host. Vol. 42[1]).
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Immunocompromised Host; Postoperative Complications; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2007 |
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Regression Analysis; Triazoles; Voriconazole | 2008 |
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2008 |
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europe; Fluconazole; Fungemia; Global Health; Humans; Latin America; Microbial Sensitivity Tests; Middle East; North America; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2008 |
Beta-D-glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients?
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Candidiasis; Chemoprevention; Humans; Leukemia; Proteoglycans; Triazoles | 2008 |
Bile aspiration for diagnosis of Candida glabrata cholecystitis.
Topics: Acalculous Cholecystitis; Aged; Animals; Antifungal Agents; Bile; Biopsy, Needle; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
Voriconazole in newborns.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole | 2008 |
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Kidney; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
[Correlation of in vitro and in vivo actions of azole antimycotics].
Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
Terconazole - a new broad-spectrum antifungal.
Topics: Administration, Oral; Animals; Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Dermatomycoses; Dose-Response Relationship, Drug; Female; Fungi; Guinea Pigs; Male; Mice; Rats; Rats, Inbred Strains; Triazoles; Trichomonas Vaginitis; Turkeys; Yeasts | 1983 |
Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candidiasis; Candidiasis, Oral; Child, Preschool; Drug Resistance, Microbial; Esophageal Diseases; Female; Humans; Male; Middle Aged; Triazoles | 1995 |
Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Male; Mice; Microbial Sensitivity Tests; Mycoses; Triazoles; Trichosporon | 1995 |
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Mice; Mice, Inbred ICR; Triazoles | 1995 |
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles | 1995 |
Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Synergism; Drug Therapy, Combination; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Spleen; Triazoles | 1994 |
Fever and leukocytosis related to terconazole vaginal suppository.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis; Female; Fever; Humans; Leukocytosis; Suppositories; Triazoles | 1994 |
Optically active antifungal azoles. I. Synthesis and antifungal activity of (2R,3R)-2-(2,4-difluorophenyl)-3-mercapto-1-(1H-1,2,4-triazol-1-yl)-2-b utanol and its stereoisomers.
Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Chromatography, Thin Layer; Fungi; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1993 |
Optically active antifungal azoles. II. Synthesis and antifungal activity of polysulfide derivatives of (2R,3R)-2-(2,4-difluorophenyl)-3-mercapto-1-(1H- 1,2,4-triazol-1-yl)-2-butanol.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Magnetic Resonance Spectroscopy; Mice; Oxidation-Reduction; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship; Sulfhydryl Compounds; Triazoles | 1993 |
Structure-activity relationships of 3-methyl and 3,3-dimethyl analogs of 2-(2,4-difluorophenyl)-3-(omega-substituted alkyl)sulfonyl-1-(1H-1,2,4-triazol-1-yl)-2-propanols.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles | 1996 |
Synthesis and antifungal activity of alkylthio and alkylsulfonyl derivatives of SM-8668.
Topics: Alkylation; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Magnetic Resonance Spectroscopy; Male; Mice; Structure-Activity Relationship; Sulfur; Triazoles | 1996 |
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles | 1996 |
ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles | 1996 |
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cryptococcus neoformans; Dogs; Fluconazole; Hydroxybutyrates; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rabbits; Rats; Triazoles | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
Efficacy of D0870 treatment of experimental Candida vaginitis.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Triazoles; Vaginitis | 1997 |
Synthesis and antifungal activity of novel thiazole-containing triazole antifungals.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida; Candidiasis; Mice; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Structure-Activity Relationship; Thiazoles; Triazoles | 1997 |
Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1997 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Synthesis and antifungal activity of novel thiazole-containing triazole antifungals. II. Optically active ER-30346 and its derivatives.
Topics: Animals; Antifungal Agents; Candidiasis; Culture Media; Fungi; Mice; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles | 1998 |
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Pyrimidinones; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiophenes; Triazoles | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1998 |
Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Colorimetry; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Tetrazolium Salts; Thiazoles; Triazoles | 1998 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Candidiasis; Drug Carriers; Humans; Leukemia, Myeloid; Liposomes; Male; Middle Aged; Triazoles; Vasculitis | 1999 |
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 1999 |
Optically active antifungal azoles. VIII. Synthesis and antifungal activity of 1-[(1R,2R)-2-(2,4-difluoro- and 2-fluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]- 3-(4-substituted phenyl)-2(1H,3H)-imidazolones and 2-imidazolidinones.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Candidiasis; Cryptococcus neoformans; Imidazoles; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Stereoisomerism; Triazoles | 1999 |
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europ
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Triazoles | 1999 |
SCH 56592.
Topics: Animals; Antifungal Agents; Candidiasis; Chagas Disease; Drugs, Investigational; Fungi; Humans; Mice; Mycoses; Parasitic Diseases; Triazoles | 1999 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Disease Models, Animal; Lung Diseases, Fungal; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2000 |
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
Voriconazole: a new triazole antifungal.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Controlled Clinical Trials as Topic; Drug Interactions; Drug Resistance, Microbial; Humans; Pyrimidines; Retrospective Studies; Tissue Distribution; Triazoles; Voriconazole | 2000 |
Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media.
Topics: Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis; Culture Media; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
Is there in vivo-in vitro correlation between antifungal susceptibility, species of Candida spp. and clinical outcome?
Topics: Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; HIV Infections; Humans; Microbial Sensitivity Tests; Neoplasms; Statistics as Topic; Treatment Outcome; Triazoles | 2000 |
Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Synergism; HIV Infections; Humans; Microbial Sensitivity Tests; Naphthalenes; Pharyngitis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
Topics: Antifungal Agents; Calibration; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida albicans; Candidiasis; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Piperazines; Treatment Outcome; Triazoles | 2001 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole | 2001 |
Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Triazoles | 2001 |
Voriconazole and fluconazole susceptibility of Candida isolates.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Injections, Intravenous; Ketoconazole; Kidney; Male; Mice; Triazoles | 1992 |
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Candidiasis; Candidiasis, Vulvovaginal; Cricetinae; Dermatomycoses; Female; Fungi; Guinea Pigs; Male; Mesocricetus; Mice; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Stereoisomerism; Triazoles; Trichophyton | 1992 |
Triazole antifungals. V. Synthesis and antifungal activities of some amides related to 3-acylamino-2-aryl-1-triazolyl-2-butanol.
Topics: Animals; Antifungal Agents; Candidiasis; Chlorobenzenes; Mice; Structure-Activity Relationship; Triazoles | 1992 |
Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Female; Kidney; Mice; Mice, Inbred ICR; Triazoles | 1991 |
Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Culture Media; Disease Models, Animal; Female; Guinea Pigs; Histoplasmosis; Humans; Mice; Mycoses; Nephritis; Rats; Sporotrichosis; Tinea; Triazoles | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Candida albicans--do mycelia matter?
Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Culture Media; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Mice; Triazoles | 1990 |
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
Topics: Agranulocytosis; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Female; Fluconazole; Immunosuppression Therapy; Rabbits; Triazoles | 1990 |
Synthesis and antifungal activities of some thiolane-triazole derivatives.
Topics: Animals; Antifungal Agents; Candidiasis; Chemical Phenomena; Chemistry; Fungi; Mice; Microbial Sensitivity Tests; Sulfhydryl Compounds; Triazoles | 1990 |
Oral fluconazole for treatment of disseminated fungal infection.
Topics: Administration, Oral; Candidiasis; Child; Female; Fluconazole; Humans; Triazoles | 1989 |
Treatment of systemic yeast infection with fluconazole.
Topics: Candidiasis; Fluconazole; Humans; Triazoles | 1989 |
[Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Triazoles | 1989 |
[Clinical evaluation of fluconazole in patients with mycotic infection].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidiasis, Oral; Drug Evaluation; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Sepsis; Tissue Distribution; Triazoles | 1989 |
[Experience of fluconazole in pediatric patients].
Topics: Administration, Oral; Adolescent; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infant; Male; Mycoses; Risk Factors; Triazoles | 1989 |
[Clinical efficacy of fluconazole in urinary tract fungal infections].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infusions, Intravenous; Male; Middle Aged; Triazoles; Urinary Tract Infections | 1989 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Fungal; Candidiasis; Child; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Esophagitis; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Mycoses; Renal Dialysis; Triazoles | 1989 |
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles | 1989 |
[Fluconazole treatment of systemic mycoses].
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Endophthalmitis; Female; Fluconazole; Humans; Leukopenia; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Triazoles | 1989 |
[AIDS fungus infections. Fluconazole--a new preparation in development].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Opportunistic Infections; Triazoles | 1989 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles | 1989 |
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent.
Topics: Adult; Antifungal Agents; Candidiasis; Dialysis Solutions; Female; Fluconazole; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Triazoles | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles | 1989 |
Fluconazole treatment of Candida glabrata peritonitis.
Topics: Adult; Candida; Candidiasis; Female; Fluconazole; Humans; Peritonitis; Triazoles | 1989 |
Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Diabetes Mellitus, Experimental; Fluconazole; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Saccharomyces cerevisiae; Triazoles | 1989 |
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Meningitis; Microbial Sensitivity Tests; Rabbits; Triazoles | 1989 |
Fluconazole in renal candidosis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Kidney Diseases; Male; Middle Aged; Triazoles | 1989 |
Fluconazole and candidosis.
Topics: Adult; Antifungal Agents; Candidiasis; Fluconazole; Heart Transplantation; Humans; Immune Tolerance; Lung Transplantation; Male; Mediastinal Diseases; Triazoles | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Rabbits; Triazoles | 1988 |
Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients.
Topics: Adult; Aged; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Fluconazole; HIV Seropositivity; Humans; Male; Middle Aged; Pharyngeal Diseases; Time Factors; Triazoles | 1988 |
Fluconazole in the treatment of candidal prosthetic valve endocarditis.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Mitral Valve; Triazoles | 1988 |
Use of fluconazole in a patient with documented malabsorption of ketoconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Fluconazole; Humans; Intestinal Absorption; Ketoconazole; Triazoles | 1988 |
Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Fluconazole; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Scleroderma, Systemic; Triazoles | 1988 |
Fluconazole resistance in Candida glabrata.
Topics: Antifungal Agents; Bile; Candida; Candidiasis; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Fluconazole; Humans; Middle Aged; Triazoles; Urine | 1988 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Ketoconazole; Mice; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1985 |
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Intestinal Diseases; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles | 1986 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraconazole; Ketoconazole; Kinetics; Male; Rabbits; Tissue Distribution; Triazoles | 1987 |
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Imidazoles; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |